ALMLB Fundamental Analysis - MILIBOO SA

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to ALMLB. ALMLB was compared to 35 industry peers in the Household Durables industry. While ALMLB seems to be doing ok healthwise, there are quite some concerns on its profitability. ALMLB is valued correctly, but it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year ALMLB has reported negative net income.

In the past year ALMLB has reported a negative cash flow from operations.

In multiple years ALMLB reported negative net income over the last 5 years.

In multiple years ALMLB reported negative operating cash flow during the last 5 years.

1.2 Ratios

The Return On Assets of ALMLB (-1.61%) is worse than 77.14% of its industry peers.

The Return On Equity of ALMLB (-3.94%) is worse than 77.14% of its industry peers.

		Industry Rank	Sector Rank
ROA	-1.61%
ROE	-3.94%
ROIC	N/A

ROA(3y)0.93%

ROA(5y)2.07%

ROE(3y)-1.09%

ROE(5y)23.82%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

ALMLB has a worse Gross Margin (26.58%) than 65.71% of its industry peers.

ALMLB's Gross Margin has been stable in the last couple of years.

The Profit Margin and Operating Margin are not available for ALMLB so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	26.58%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y0.1%

GM growth 5Y1.16%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ALMLB does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for ALMLB remains at a similar level compared to 1 year ago.

ALMLB has more shares outstanding than it did 5 years ago.

The debt/assets ratio for ALMLB has been reduced compared to a year ago.

2.2 Solvency

An Altman-Z score of 3.34 indicates that ALMLB is not in any danger for bankruptcy at the moment.

ALMLB's Altman-Z score of 3.34 is fine compared to the rest of the industry. ALMLB outperforms 80.00% of its industry peers.

A Debt/Equity ratio of 0.15 indicates that ALMLB is not too dependend on debt financing.

Looking at the Debt to Equity ratio, with a value of 0.15, ALMLB belongs to the top of the industry, outperforming 82.86% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.15
Debt/FCF	N/A
Altman-Z	3.34

ROIC/WACCN/A

WACC7.02%

2.3 Liquidity

A Current Ratio of 1.78 indicates that ALMLB should not have too much problems paying its short term obligations.

With a decent Current ratio value of 1.78, ALMLB is doing good in the industry, outperforming 62.86% of the companies in the same industry.

ALMLB has a Quick Ratio of 1.78. This is a bad value and indicates that ALMLB is not financially healthy enough and could expect problems in meeting its short term obligations.

ALMLB's Quick ratio of 0.85 is in line compared to the rest of the industry. ALMLB outperforms 51.43% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.78
Quick Ratio	0.85

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for ALMLB have decreased strongly by -110.80% in the last year.

The Revenue for ALMLB has decreased by -10.02% in the past year. This is quite bad

The Revenue has been growing slightly by 5.42% on average over the past years.

EPS 1Y (TTM)-110.8%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-133.16%

Revenue 1Y (TTM)-10.02%

Revenue growth 3Y-0.18%

Revenue growth 5Y5.42%

Sales Q2Q%-7.29%

3.2 Future

Based on estimates for the next years, ALMLB will show a very negative growth in Earnings Per Share. The EPS will decrease by -31.83% on average per year.

The Revenue is expected to decrease by -8.53% on average over the next years.

EPS Next Y17.64%

EPS Next 2Y0.93%

EPS Next 3Y-31.83%

EPS Next 5YN/A

Revenue Next Year-8.57%

Revenue Next 2Y-6.23%

Revenue Next 3Y-8.53%

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALMLB. In the last year negative earnings were reported.

Based on the Price/Forward Earnings ratio of 4.84, the valuation of ALMLB can be described as very cheap.

Compared to the rest of the industry, the Price/Forward Earnings ratio of ALMLB indicates a rather cheap valuation: ALMLB is cheaper than 94.29% of the companies listed in the same industry.

ALMLB is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.59, which is the current average of the S&P500 Index.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	4.84

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALMLB is valued a bit more expensive than the industry average as 71.43% of the companies are valued more cheaply.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	2440.46

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

ALMLB's earnings are expected to decrease with -31.83% in the coming years. This may justify a cheaper valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y0.93%

EPS Next 3Y-31.83%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

ALMLB does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

MILIBOO SA

EPA:ALMLB (11/28/2025, 7:00:00 PM)

1.51

+0.06 (+4.5%)

Chartmill FA Rating

GICS SectorConsumer Discretionary

GICS IndustryGroupConsumer Durables & Apparel

GICS IndustryHousehold Durables

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst Owners43%

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap10.46M

Revenue(TTM)38.98M

Net Income(TTM)-257.00K

AnalystsN/A

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	4.84
P/S	0.27
P/FCF	N/A
P/OCF	N/A
P/B	1.6
P/tB	2.43
EV/EBITDA	2440.46

EPS(TTM)-0.04

EYN/A

EPS(NY)0.31

Fwd EY20.65%

FCF(TTM)-0.18

FCFYN/A

OCF(TTM)-0.06

OCFYN/A

SpS5.62

BVpS0.94

TBVpS0.62

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-1.61%
ROE	-3.94%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	26.58%
FCFM	N/A

ROA(3y)0.93%

ROA(5y)2.07%

ROE(3y)-1.09%

ROE(5y)23.82%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y0.1%

GM growth 5Y1.16%

F-Score2

Asset Turnover2.45

Health

		Industry Rank	Sector Rank
Debt/Equity	0.15
Debt/FCF	N/A
Debt/EBITDA	236.75
Cap/Depr	162.09%
Cap/Sales	2.15%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.78
Quick Ratio	0.85
Altman-Z	3.34

F-Score2

WACC7.02%

ROIC/WACCN/A

Cap/Depr(3y)200.54%

Cap/Depr(5y)208.68%

Cap/Sales(3y)2.1%

Cap/Sales(5y)2.06%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-110.8%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-133.16%

EPS Next Y17.64%

EPS Next 2Y0.93%

EPS Next 3Y-31.83%

EPS Next 5YN/A

Revenue 1Y (TTM)-10.02%

Revenue growth 3Y-0.18%

Revenue growth 5Y5.42%

Sales Q2Q%-7.29%

Revenue Next Year-8.57%

Revenue Next 2Y-6.23%

Revenue Next 3Y-8.53%

Revenue Next 5YN/A

EBIT growth 1Y-118.29%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year85.04%

EBIT Next 3Y-21.18%

EBIT Next 5YN/A

FCF growth 1Y-215.16%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-118.08%

OCF growth 3YN/A

OCF growth 5YN/A

MILIBOO SA / ALMLB.PA FAQ

What is the ChartMill fundamental rating of MILIBOO SA (ALMLB.PA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to ALMLB.PA.

What is the valuation status for ALMLB stock?

ChartMill assigns a valuation rating of 4 / 10 to MILIBOO SA (ALMLB.PA). This can be considered as Fairly Valued.

How profitable is MILIBOO SA (ALMLB.PA) stock?

MILIBOO SA (ALMLB.PA) has a profitability rating of 1 / 10.

Can you provide the financial health for ALMLB stock?

The financial health rating of MILIBOO SA (ALMLB.PA) is 4 / 10.

MILIBOO SA (ALMLB.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

MILIBOO SA / ALMLB.PA FAQ

What is the ChartMill fundamental rating of MILIBOO SA (ALMLB.PA) stock?

What is the valuation status for ALMLB stock?

How profitable is MILIBOO SA (ALMLB.PA) stock?

Can you provide the financial health for ALMLB stock?